Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sun, Jin"'
Autor:
Sung Youb Jung, Sang Hyun Lee, In Young Choi, Jeong A. Kim, Young Hoon Kim, Sun Jin Kim, Sang Don Lee
Publikováno v:
Diabetes. 67
HM15211 is a novel long-acting GLP-1/GIP/Glucagon triple agonist that is being developed for the treatment of obesity and nonalcoholic fatty liver disease (NASH). Accumulating evidences have shown that obesity, type 2 diabetes, and NASH increase the
Autor:
Sang Hyun Lee, In Young Choi, Sung Youb Jung, Sun Jin Kim, Jae Hyuk Choi, Jong Suk Lee, Jung Kuk Kim
Publikováno v:
Diabetes. 67
Obesity is an established risk factor for prediabetes, diabetes and the aggravation of preexisting diabetes by negatively affecting lipid metabolism, insulin response, and β-cell function. Thus, effective body weight loss not only prevents or delays
Autor:
In Young Choi, Yu-Yon Kim, Sun Jin Kim, Jong Suk Lee, Young Hoon Kim, Sang Don Lee, Sang Hyun Lee
Publikováno v:
Diabetes. 67
Severe weight loss is often associated with reduction of bone mineral density (BMD) and an imbalance between bone formation and reabsorption in obese people. As a consequence, there can be an increased risk of bone fractures with body weight loss. Se
Autor:
Younghoon Kim, Jung Kuk Kim, Eunjin Park, Sun Jin Kim, Jong Suk Lee, Sung Youb Jung, In Young Choi
Publikováno v:
Diabetes. 67
Nonalcoholic steatohepatitis (NASH), a potential consequence of NAFLD, may lead to end stage liver disease including cirrhosis and hepatocellular carcinoma. Despite its severity and prevalence, NASH currently lacks effective treatment. In this respec